Skip to main content
. 2012 Jan-Mar;16(1):105–111. doi: 10.4293/108680812X13291597716221

Table 2.

Comparison Between Groups

Visual Analog Scaleb Processing Group (Bupivacaine) n=30 Control Group (Placebo) n=30 P
Pain T0 1 (1–2) 2 (1–5) .070
p50 (p25–p75)
Pain T6 3.50 (2.75–5) 5 (4–5.25) .02a
p50 (p25–p75)
Pain T12 3 (2–4) 4 (3–5) .605
p50 (p25–p75)
Pain T24 1.50 (1–2) 2 (1–2) .704
p50 (p25-p75)

Statistically significant.

b

p50, median; p25-p50, interquartile rank.